Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 9 Neoplasms 4 Melanoma 4 Breast Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Sarcoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Pleural Effusion, Malignant 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Anxiety Disorders 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Recurrence 1 Rare Malignant Neoplasm 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 NSCLC 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphedema 1 Locally Advanced Bladder Cancer 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

Pharmaceutical Preparations 1 Electroporation 1 Electrochemotherapy 1 Cisplatin 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gynecological Cancers × Pharmaceutical Preparations × Clear all

NCT04760327 2024-10-17

GynECT

Institute of Oncology Ljubljana

Phase 2 Recruiting

Gynecological Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡